Featured Research

from universities, journals, and other organizations

Regional use of minimally invasive repair of aneurysms examined

Date:
April 2, 2010
Source:
Cedars-Sinai Medical Center
Summary:
While health policy researchers commonly suggest that geographic variations in the amount of medical care provided can be attributed to hospital costs or physician practice patterns, a new study examining regional utilization of a specific surgical procedure -- minimally invasive aneurysm repair -- shows that is not the case.

While health policy researchers commonly suggest that geographic variations in the amount of medical care provided can be attributed to hospital costs or physician practice patterns, a new study examining regional utilization of a specific surgical procedure -- minimally invasive aneurysm repair -- shows that is not the case.

Researchers at Cedars-Sinai Medical Center in Los Angeles have found that the utilization of endovascular aortic abdominal aneurysm repair was not associated with physician capacity and distribution, socioeconomics or other non-medical factors, but rather with a patient's cardiovascular risk factors, disease prevalence and the clinical judgment of physicians.

Details of this study were reported in the April issue of the Journal of Vascular Surgery.

Endovascular aortic abdominal aneurysm repair is a procedure to repair a ballooning of the aorta, and is similar to the stent placement in a coronary artery after angioplasty. While the total number of aneurysms found in the population has remained about the same over the last several decades, the number of aortic aneurysm repairs performed as open surgeries has decreased by 48 percent, while the number of aneurysms repaired endovascularly increased by more than 100 percent since the procedure was introduced in the 1990s.

"Until now, little has been known about what medical and non-medical factors influence the use of minimally invasive vascular surgical repair," said Bruce Gewertz, MD, chair of the department of surgery at Cedars-Sinai Medical Center and the study's principal investigator. "But because vascular surgeons perform both open and minimally invasive aneurysm repair, the data on decision-making aspects of the patients' medical care could be analyzed in a more straight forward manner."

"In the study, we found that increased use of the endovascular procedure to repair an aortic abdominal aneurysm correlated most closely with higher-risk patient populations and with physicians who were more experienced in treating aneurysms," said Gewertz, who is also surgeon-in-chief and the Harriet and Steven Nichols Endowed Chair in Surgery at Cedars-Sinai Medical Center "Contrary to some conventional thinking, use was not strongly influenced by many of the economic factors previously thought to be predictive."

Researchers examined the use of endovascular aortic abdominal aneurysm repair from 2001 to 2006 across 29 states to test the hypothesis that the utilization of innovative vascular procedures by vascular surgeons more closely reflects disease prevalence and consistent clinical judgment than non-medical considerations. The utilization rates varied widely between states, from 39.3 percent to 69.9 percent; use of the procedure was highest in states with higher incidences of aneurysms and a greater number of deaths from heart disease.

A previous investigation by the research team showed that variations in the rates of carotid endarterectomy actually reflected regional risk factors for atherosclerosis not physician density of other socioeconomic drivers.

"By documenting disparities and variations in care, this study -- and others like them -- can help define best practice treatment pathways and may lead to new ways to examine inequalities in preventive diagnostic and therapeutic inefficiencies at the systems level," said Gewertz.

Data for the study was taken from the Nationwide Inpatient Samples and State Inpatient Datebases.


Story Source:

The above story is based on materials provided by Cedars-Sinai Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

Cedars-Sinai Medical Center. "Regional use of minimally invasive repair of aneurysms examined." ScienceDaily. ScienceDaily, 2 April 2010. <www.sciencedaily.com/releases/2010/04/100402110139.htm>.
Cedars-Sinai Medical Center. (2010, April 2). Regional use of minimally invasive repair of aneurysms examined. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2010/04/100402110139.htm
Cedars-Sinai Medical Center. "Regional use of minimally invasive repair of aneurysms examined." ScienceDaily. www.sciencedaily.com/releases/2010/04/100402110139.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins